PLiu JJ, Ching J, Wee HN , Liu S, Gurung RL, Lee J, MY, Zheng H, Lee LS, Ang K, Shao YM, Kovalik JP, Subramaniam T, Sum CF, Sharma K, Kestenbaum BR, Lim SC. Plasma Tryptophan-Kynurenine Pathway Metabolites and Risk for Progression to End-Stage Kidney Disease in Patients With Type 2 Diabetes. Diabetes Care 2023;46(12):2223-223 (IF 17.1) 2. Liu JJ, Liu S, Wang J, Pek SLT, Lee J, Gurung RL, Ang K, Shao YM, Tavintharan S, Tang WE, Sum CF and Lim SC. Urine leucine-rich alpha-2 glycoprotein 1 (LRG1) predicts the risk for progression to end stage kidney disease in patients with type 2 diabetes. Diabetes Care 2023;46(2):408–415 (IF 17.1)
Wang J, Liu JJ et al. Clinical variable-based cluster analysis identifies novel subgroups with a distinct genetic signature, lipidomic pattern and cardio-renal risks in Asian patients with type 2 diabetes. Diabetologia 2022;65(12):2146-56 (IF: 10.1)
Liu JJ, Liu S, Wang J, Lee J, Tang JIS, Gurung RL, Ang K, Shao YM, Tavintharan S, Tang WE, Sum CF, Lim SC. Risk of incident heart failure in individuals with early-onset type 2 diabetes. J Clin Endocrinol Metab 2022;107(1):e178-e187 (IF 6.0)
Wee HN, Liu JJ, Ching J and Kovalik JP and Lim SC. The Kynurenine Pathway in Acute Kidney Injury and Chronic Kidney Disease. Am J Nephrol 2021;52:771-787 (IF 4.6)
Liu JJ, Pek SLT, Wang JX, Liu S, Ang K, Shao YM, Tang JIS, Gurung RL, Tavintharan S, Tang WE, Sum CF and Lim SC. Association of plasma leucine-rich alpha-2 glycoprotein 1 (LRG1), a modulator of TGF-beta signalling pathway, with incident heart failure in individuals with type 2 diabetes. Diabetes Care 2021;44:571-577 (IF 17.1)
Liu JJ, Pek SLT, Liu S, Wang J, Lee J, Ang K, Shao YM, Gurung RL, Tavintharan S, Tang W, Sum CF, Lim SC. Association of plasma leucine-rich alpha-2 glycoprotein 1 (LRG1) with all-cause and cause-specific mortality in individuals with type 2 diabetes. Clin Chem 2021;67(12):1640-1649 (IF 12.2)
Liu JJ, Gurung RL, Liu S, Yiamunaa M, Lee J, Ang K, Tavintharan S, Tang WE, Sum CF, Lim SC. Association of young-onset age and genetic risk of beta cell dysfunction with glycaemic progression in individuals with type 2 diabetes. Diabetes Metab 2021;47(6):101238 (IF: 8.3)
Liu JJ et al. Risk of progressive chronic kidney disease in individuals with early-onset type 2 diabetes: a prospective cohort study. Nephrology Dialysis Transplantation 2020; 35:115-121 (IF: 6.0)
Liu JJ et al. Association of urine haptoglobin with risk of all-cause and cause-specific mortality in individuals with type 2 diabetes- a trans-ethnic collaborative work. Diabetes Care 2020;43:625-633 (IF: 19.2)
Liu JJ, Liu S, Gurung RL, Ang K, Tang WE, Sum CF, Tavintharan S, Hadjadj S and Lim SC. Arterial stiffness modulates the association of resting heart rate with rapid renal function decline in individuals with type 2 diabetes. Arteriosclerosis Thrombosis and Vascular Biology 2019;39:2437-2444 (IF 10.5)
- Liu JJ et al. Urine tricarboxylic acid (TCA) cycle metabolites predict progressive chronic kidney disease in type 2 diabetes. J Clin Endo Metab 2018;103:4357-4364 (IF:6.0)
